Analysis of glutathione s-transferase (m1, t1 and p1) gene polymorphisms in iranian prostate cancer subjects

African Journal of Biotechnology

Volumn 9, Issue 43, 2010, Pages 7230-7235

  Ansari, Sahar B ^a   Vasudevan, R ^a   Bakhshi, Ali ^a   Mirinargesi, M ^a,b   Patimah, I ^a   Sabariah, A R ^a   Pasalar, P ^c  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Glutathione s transferase; Polymorphism; Prostate cancer

Indexed keywords

ADENOSINE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; GUANIDINE;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; NULL ALLELE; PROSTATE CANCER; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 78549263694     PISSN: 16845315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Ali-Osman F, Akande O, Antoun G, Mao JX, Buolamwini J (1997). Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J. Biol. Chem. 272: 10004-10012.
2. Buch SC, Notani PN, Bhisey RA (2002). Polymorphism at GSTM1, GSTM3 and GSTT1 gene loci and susceptibility to oral cancer in an Indian population. Carcinogenesis, 23: 803-807.
3. D'Errico A, Taioli E, Xhen X, Vineis P (1996). Genetic polymorphism and the risk of cancer: A review of the literature. Biomarkers, 1: 149-173.
4. Dekant W, Vamvakas S (1993). Glutathione-dependent bioactivation of xenobiotics. Xenobiotica, 23: 873-877.
5. Ewis AA, Lee J, Naroda T, Sasahra K, Sano T, Kagawa S, Iwamoto T, Nakahori Y (2002). Linkage between prostate cancer incidence and different alleles of the human Y-Linked tetranucleotide polymorphism DYS19. J. Med. Invest. 49: 56-60.
6. Gsur A, Haidinger G, Hinteregger S (2001). Polymorphisms of glutathione-Stransferase genes (GSTP1, GSTM1 and GSTT1) and prostate-cancer risk. Int. J. Cancer, 95:152-155.
7. Guengerich FP, Their R, Persmark M, Taylor JB, Pemble SE, Ketterer B (1995). Conjugation of carcinogen by theta class glutathione Stransferase; mechanism and relevance to variations in human risk. Pharmacogenetics, 5: 103-107.
8. Hayes JD, Pulford DJ (1995). The glutathione S-transferase supergene family: Regulation of GST and the contribution of isoenzymes to cancer chemoprotection and drug resistance. Crit. Rev. Biochem. Mol. Biol. 30: 445-600.
9. Hsing A, Tsao L, Devesa S (2000). International trends and patterns of prostate cancer incidence and mortality. Int. J. Cancer, 85: 60-67.
10. Ketterer B, Harris JM, Talaska G (1992). The human glutathione Stransferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer. Environ. Health. Perspect. 98: 87-94.
11. Kolonel L N, Altshuler D, Henderson BE (2004). The multiethnic cohort study: Exploring genes, lifestyle and cancer risk. Nat. Rev. Cancer, 4: 519-517.
12. Kote-Jarai Z, Easton D, Edwards SM, Jefferies S, Durocher F, Jackson RA (2001). Relationship between glutathione S-transferase M1, P1 and T1 polymorphisms and early onset prostate cancer. Pharmacogenetics, 1: 325-330.
13. Mayer F, Bairati I, Shadmani R, Fradet Y and Moore L (1999). Dietary fat and prostate cancer survival. Eur. Urol. pp. 245-251.
14. Medeiros R, Vasconcelos A, Costa S (2004). Metabolic susceptibility genes and prostate cancer risk in a southern European population: The role of glutathione Stransferases GSTM1, GSTM3, and GSTT1 genetic polymorphisms. Prostate, 58: 414-420.
15. Mittal RD, Srivastava DSL, Mandhani A, Kumar A, Mittal B (2004). Polymorphism of GSTM1 and GSTT1 genes in prostate cancer: A study from north India. Indian J. Cancer, 3: 115-119.
16. Nair UJ, Nair J, Mathew B, Bartsch H (1999). Glutathione S-transferase M1 and T1 null genotypes as risk factors for oral leukoplakia in ethnic Indian betal quid/tobacco chewers. Carcinogenesis, 20: 743-748.
17. Nakazato H, Suzuki K, Matsui H (2003). Association of genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk in Japanese population. Anticancer Res. 23: 2897-2902
18. Ornish D, Jesus MM, Magbanua (2008). Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyleintervention. Proc. Natl. Acad. Sci. USA, 105: 8369-8374.
19. Pemble S, Schroeder KR, Spencer SR (1994). Human glutathione Stransferase theta (GSTT1): cDNA cloning and the characterization of genetic polymorphism. Biochemical, 300: 271-276.
20. Rebbeck TR, Walker AH, Jaffe JM, White DL, Wein AJ, Malkowicz SB (1999). Glutathione S-transferase-mu (GSTM1) and-theta (GSTT1) genotypes in the etiology of prostate cancer. Cancer. Epidemiol. Biomarkers Prev. 8: 283-287.
21. Safarinejad MR (2006). Population-based screening for prostate cancer by measuring free and total serum prostate-specific antigen in Iran. Ann. Oncol. 7: 1166-1171.
22. Srivastava SS, Anil M, Mittal B, Mittal RD (2004). Genetic polymorphism of glutathione S- transferase genes (GSTT1, GSTM1 and GSTP1) and susceptibility to prostate cancer in Northern India. Indian J. Cancer, 95: 70-173.
23. Steinhoff C, Franke KH, Golka K (2000). Glutathione transferase isozyme genotypes in patients with prostate and bladder carcinoma. Arch. Toxicol. 74: 521-526.
24. Vander-Gulden JW, Kolk JJ, Verbeek AL (1992). Prostate cancer and work environment. J. Occup. Med. 34: 402-409.
25. Wiencke JK, Pemble S, Ketterer B, Kelsey KT (1995). Gene deletion of glutathione S-transferase theta: correlation with induced genetic damage and potential role in endogenous mutagenesis. Cancer Epidemiol. Biomarkers Prev. 4: 253-259.